![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » UK CLAIMS MASSIVE SAVINGS FROM ANTI-FRAUD OPERATIONS
UK CLAIMS MASSIVE SAVINGS FROM ANTI-FRAUD OPERATIONS
UK government healthcare provider the National Health Service has claimed that anti-fraud initiatives have saved the organisation some GBP675mn (US$1.19bn) since 1998. The NHS also claims that its Counter Fraud Service has a 96% success rate in criminal prosecutions, and reports a sharp decline in corrupt activity among staff and patients.
Meanwhile, these claims of success come as two criminal investigations into alleged price-fixing by major generics companies draw to a close in the UK. Two leading international firms recently settled in an NHS investigation, but reports claim that positive results in a separate probe by the failure-prone Serious Fraud Office (SFO) are less likely. The SFO is expected to bring a formal prosecution in October.
KEYWORDS Daily International Pharma Alert
Upcoming Events
-
21Oct